Plant ID: NPO2669
Plant Latin Name: Bowdichia virgilioides
Taxonomy Genus: Bowdichia
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
149685
Plant-of-the-World-Online:
n.a.
Brazil
TP53; | |
SLCO1B3; SLCO1B1; | |
LMNA; RAB9A; NPC1; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 2.892E-06 | 6.297E-02 | CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 8.667E-06 | 8.977E-02 | CYP2C19, CYP2C9 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.271E-05 | 8.977E-02 | CYP2C19, CYP2C9 |
MF | GO:0003824; catalytic activity | GO:0008392; arachidonic acid epoxygenase activity | 2.615E-05 | 8.977E-02 | CYP2C19, CYP2C9 |
MF | GO:0005215; transporter activity | GO:0015125; bile acid transmembrane transporter activity | 2.941E-05 | 8.977E-02 | SLCO1B1, SLCO1B3 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 4.034E-05 | 9.760E-02 | CYP2C19, CYP2C9 |
MF | GO:0005215; transporter activity | GO:0015347; sodium-independent organic anion transmembrane transporter activity | 5.298E-05 | 1.154E-01 | SLCO1B1, SLCO1B3 |
BP | GO:0051179; localization | GO:0043252; sodium-independent organic anion transport | 7.249E-05 | 1.435E-01 | SLCO1B1, SLCO1B3 |
BP | GO:0051179; localization | GO:0015721; bile acid and bile salt transport | 8.338E-05 | 1.513E-01 | SLCO1B1, SLCO1B3 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 1.639E-04 | 2.422E-01 | CYP2C19, CYP2C9, NPC1 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.891E-04 | 2.422E-01 | CYP2C19, CYP2C9 |
CC | GO:0044464; cell part | GO:0005635; nuclear envelope | 2.451E-03 | 9.362E-01 | LMNA, NPC1 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 3.176E-03 | 1.000E+00 | SLCO1B1, SLCO1B3 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 4.210E-03 | 1.000E+00 | CYP2C19, CYP2C9, LMNA, NPC1, RAB9A |
CC | GO:0044464; cell part | GO:0005764; lysosome | 6.758E-03 | 1.000E+00 | NPC1, RAB9A |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 7.311E-03 | 1.000E+00 | CYP2C19, CYP2C9, RAB9A |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 7.262E-05 | 3.559E-03 | CYP2C9, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 3.357E-04 | 5.392E-03 | CYP2C9, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 4.157E-04 | 5.392E-03 | CYP2C9, CYP2C19 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 4.402E-04 | 5.392E-03 | SLCO1B1, SLCO1B3 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.091E-03 | 8.906E-03 | CYP2C9, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 5.867E-04 | 5.750E-03 | CYP2C9, CYP2C19 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 1.696E-03 | 1.039E-02 | LMNA, TP53 |
09160 Human Diseases | 09167 Infectious diseases | hsa05162 | Measles | 1.602E-03 | 1.039E-02 | RAB9A, TP53 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04115 | p53 signaling pathway | 3.063E-02 | 6.700E-02 | TP53 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.238E-02 | 6.700E-02 | CYP2C9 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Cancer | C00-C96 | TP53; |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | TP53; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TP53; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | TP53; |
I00-I99: Diseases of the circulatory system | Renal artery disease | I70.1 | TP53; |
H60-H95: Diseases of the ear and mastoid process | Hearing disorder | H90.5 | TP53; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | TP53; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Toxicity | T36-T50, T51-T65 | TP53; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TP53; |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53; |